Scroll to top
Follow Us
–
Fb.
Tw.
Li.
Yt.
Inst.
Skip to content
About
Company
About CLINUVEL
Risk Management & ESG Statement
Mission, Vision & Values
History & Future
People
Board
Management
Corporate Governance
Pharmaceutical Technology
SCENESSE®
About Melanocortins
Published Research
Scientific Communiqués
Pipeline
Disease Entities
Erythropoietic Protoporphyria
Variegate Porphyria
Vitiligo
DNA Repair
Xeroderma Pigmentosum
Arterial Ischaemic Stroke
Healthcare Solutions
Investors
News
Latest News
Share Price
Announcements Calendar
CLINUVEL Online
ASX Announcements
Company Snapshot
Financial Overview
Shareholder Information
Media Coverage
Analyst Coverage
Annual Reports
Enquiries
FAQ
© CLINUVEL PHARMACEUTICALS LTD 2020 All right reserved. |
Sitemap
|
Disclaimer
|
Privacy Policy
Follow Us
–
Fb.
Tw.
Li.
Yt.
Inst.
Contact Us
Search for
Back
Financial
1 min read
Appendix 4E and Preliminary Financial Report 2020
Author
CLINUVEL
Published
August 27, 2020
Home
News
Financial
Appendix 4E and Preliminary Financial Report 2020
Download PDF
Recent Posts
Posted by
CLINUVEL
October 26, 2020
Financial
News
1 min read
CLINUVEL Pharmaceuticals Limited (ASX: CUV) – Trading Halt
CUV – Trading Halt Letter
Read More
Posted by
CLINUVEL
August 27, 2020
Financial
1 min read
CLINUVEL Declares Full Year Dividend
Download PDF
Read More
We use cookies to give you the best experience.
Cookie Details
